ANTIMICROBIAL ACTIVITY OF CORE-SHELL STRUCTURED MESOPOROUS SILICA NANOPARTICLES  
UCLA Technology Available For Licensing

Researchers at UCLA have developed a way to encapsulate antimicrobial nanoparticles inside of mesoporous silica particles to provide a robust method for targeted delivery of nanoparticles into critical areas for antimicrobial and bactericidal applications.

BACKGROUND:  Recent efforts involving bactericides have been focused on ways to aid in the delivery of this material to sites that can benefit from its application. Incorporating antimicrobial materials into bandages for use in wound and burn treatment and into membranes for water purification are some of the attractive opportunities for these materials.

INNOVATION:  Researchers at UCLA have identified a method for encapsulating antimicrobial nanoparticles inside of mesoporous silica particles, to allow for the controlled release of chemicals for antimicrobial applications. The robust mesoporous silica shell protects the core antimicrobial nanoparticles from aggregation and fast dissolution, and provides support for surface modification with functional groups.

POTENTIAL APPLICATIONS 

ADVANTAGES

Reference: UCLA Case No. 2009-002

For additional technical details and current licensing
availability, please contact the following UCLA office:

UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
NCD URL:   http://www.research.ucla.edu/tech/ucla09-002.htm

Lead Inventor: Jeffrey Zink

UCLA Technologies Available for Licensing
http://www.research.ucla.edu/oipa/industry

Copyright © 2009 The Regents of the University of California.

keywords: biomedical, chemicals, drug delivery, materials, nanotechnology, therapeutic, mesoporous silica, silver nanoparticles, antimicrobial, bactericide uclancd ucla latest inventions technology top ten 10 technologies intellectual property patents technology transfer invention business card